The effect of cold-chain re-introduction on the molecular integrity of rocuronium bromide

D. Vermeulen, M. Wooding, K. Outhoff, T. Dippenaar
{"title":"The effect of cold-chain re-introduction on the molecular integrity of rocuronium bromide","authors":"D. Vermeulen, M. Wooding, K. Outhoff, T. Dippenaar","doi":"10.36303/SAJAA.2021.27.1.2415","DOIUrl":null,"url":null,"abstract":"Introduction: This study aimed to examine the effect of breakages and re-introduction into cold chain on the rocuronium bromide compound. Rocuronium bromide is frequently used in routine theatre lists and plays a vital role in modified rapid sequence induction and intubation for emergency patients who have contraindications to the primarily used muscle relaxant, succinylcholine. With the current practice of removing the drug from, and then reintroducing it into the cold chain, unpredictable clinical effects, including delayed onset of action and shortened duration of action have been observed. This may pose significant risks to the patient.\n\nMethods: Rocuronium bromide was subjected to different clinically applicable storage and temperature scenarios, after which the compound was analysed for integrity and quantities of the active compound, including detection of possible degradation products, by mass spectrometry, and compared to cold chain control samples.\n\nResults: There were no significant differences between any of the temperature exposure groups (18 °C or 24 °C) or between single or double exposures at these temperatures. No statistically significant difference could be demonstrated between the two control groups (cold chain preserved and room temperature controlled) with testing done at weeks one and six. However, week twelve analysis revealed a statistically significant result which translates to a 26 μg/ml difference, which clinically would have no effect. Substantial results were obtained with a secondary exposure to air; which lead to a 20% decrease in rocuronium concentration (p = 0.02).\n\nConclusion: Practice should be adapted by keeping careful documentation as to when cold-chain was broken, and when the recommended 12 week period will lapse. Vial sharing as a standard is not recommended. If small quantities are repeatedly withdrawn from the vial during a prolonged case, the unused contents should be discarded after eight hours.","PeriodicalId":21769,"journal":{"name":"Southern African Journal of Anaesthesia and Analgesia","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2021-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Southern African Journal of Anaesthesia and Analgesia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36303/SAJAA.2021.27.1.2415","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: This study aimed to examine the effect of breakages and re-introduction into cold chain on the rocuronium bromide compound. Rocuronium bromide is frequently used in routine theatre lists and plays a vital role in modified rapid sequence induction and intubation for emergency patients who have contraindications to the primarily used muscle relaxant, succinylcholine. With the current practice of removing the drug from, and then reintroducing it into the cold chain, unpredictable clinical effects, including delayed onset of action and shortened duration of action have been observed. This may pose significant risks to the patient. Methods: Rocuronium bromide was subjected to different clinically applicable storage and temperature scenarios, after which the compound was analysed for integrity and quantities of the active compound, including detection of possible degradation products, by mass spectrometry, and compared to cold chain control samples. Results: There were no significant differences between any of the temperature exposure groups (18 °C or 24 °C) or between single or double exposures at these temperatures. No statistically significant difference could be demonstrated between the two control groups (cold chain preserved and room temperature controlled) with testing done at weeks one and six. However, week twelve analysis revealed a statistically significant result which translates to a 26 μg/ml difference, which clinically would have no effect. Substantial results were obtained with a secondary exposure to air; which lead to a 20% decrease in rocuronium concentration (p = 0.02). Conclusion: Practice should be adapted by keeping careful documentation as to when cold-chain was broken, and when the recommended 12 week period will lapse. Vial sharing as a standard is not recommended. If small quantities are repeatedly withdrawn from the vial during a prolonged case, the unused contents should be discarded after eight hours.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
冷链再引入对罗库溴铵分子完整性的影响
引言:本研究旨在检验断裂和重新引入冷链对罗库溴化合物的影响。罗库溴铵经常用于常规手术室名单,在对主要使用的肌肉松弛剂琥珀酰胆碱有禁忌症的急诊患者的改良快速序列诱导和插管中发挥着至关重要的作用。根据目前将药物从冷链中移除,然后将其重新引入冷链的做法,观察到了不可预测的临床效果,包括作用延迟和作用持续时间缩短。这可能会给患者带来重大风险。方法:将罗库溴化铵置于不同的临床适用储存和温度条件下,然后通过质谱法分析该化合物的完整性和活性化合物的数量,包括检测可能的降解产物,并与冷链对照样品进行比较。结果:在任何温度暴露组(18°C或24°C)之间,或在这些温度下的单次或两次暴露之间,都没有显著差异。在第一周和第六周进行的测试中,两个对照组(冷链保存组和室温控制组)之间没有统计学上的显著差异。然而,第12周的分析显示了一个具有统计学意义的结果,即26μg/ml的差异,这在临床上没有影响。二次暴露在空气中获得了实质性的结果;这导致罗库浓度下降20%(p=0.02)。结论:应通过仔细记录冷链何时断裂以及建议的12周期限何时到期来调整实践。不建议将小瓶共享作为标准。如果在长时间的情况下重复从小瓶中取出少量,则应在八小时后丢弃未使用的内容物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.90
自引率
0.00%
发文量
10
期刊最新文献
“Belt and braces”: prophylactic vasoconstrictors after spinal blocks in the elderly The profile of female anaesthesiologists in South Africa: past and present Leadership dynamics and gender transformation in anaesthesiology in South Africa When CO 2 goes wild – a tale of surgical emphysema, pneumothorax and a gas-filled adventure in laparoscopic hernia repair Optimal dose of phenylephrine infusion in the prevention of spinal anaesthesia-induced hypotension in elderly patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1